Asset overview
Program snapshot
Target: BCMA
Cell type: NK_CELL
Indications: Multiple Myeloma, Refractory
Sponsor: Shahid Beheshti University of Medical Sciences
Institution: Shahid Beheshti University of Medical Sciences
Car Nk
Anti-BCMA CAR-NK
Anti-BCMA CAR-NK is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at Shahid Beheshti University of Medical Sciences, with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Clinical evidence
Trial footprint
Phase: Phase1
Status: Not Yet Recruiting
Trial count: 1
Active trials: 0
First posted: February 5, 2024
Last updated: March 6, 2024
Signal summary
IP and BD posture
IP signal: Unlinked
BD label: Low Confidence
Confidence: Low
Manual review required: Yes
Scores
Deterministic scoring
Clinical translation0
IP linkage0
Licensing clarity3
Strategic interest3
Source
Public trial record
Review the underlying ClinicalTrials.gov record and treat Treelip output as a prioritization layer, not a final diligence conclusion.
NCT IDs: NCT06242249